Skip to content

Insider · CIK 0001699914

Robert A. Michael

ceoofficerdirector

Files at ABBV (AbbVie Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 28, 2025ABBV
AbbVie Inc.
FTax withholding
Common Stock, $0.01 par value
-27,186$205.02$5.6M132,821Mar 4, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+24,732$0.00$0123,377Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+10,146$0.00$0133,523Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+12,030$0.00$0145,553Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+14,454$0.00$0160,007Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Option (Right to Buy)derivative
+83,333$0.00$083,333Feb 18, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Robert A. Michael: insider trades and track record | InsiderTell